Home > Financial Ratios > NGL FINECHEM

NGL FINECHEM
Core EBITDA Growth

    Back to All Ratios
NGL FINECHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -36.0267.63-48.67-10.49286.35

What is the latest Core EBITDA Growth ratio of NGL FINECHEM ?

The latest Core EBITDA Growth ratio of NGL FINECHEM is -36.02 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-36.02
Mar202467.63
Mar2023-48.67
Mar2022-10.49
Mar2021286.35

How is Core EBITDA Growth of NGL FINECHEM Trending?

Years Core EBITDA Growth % Change
Mar2025 -36.02
Negative
Mar2024 67.63
Positive
Mar2023 -48.67
Negative
Mar2022 -10.49
Negative
Mar2021 286.35 -

Other Financial Ratios of NGL FINECHEM


Compare Core EBITDA Growth ratio of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹893.9 Cr -3.1% 7.7% -34.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹387,792.0 Cr 2.3% -0.4% -12.4% Stock Analytics
DIVIS LABORATORIES ₹159,986.0 Cr 0% 1.1% 10.7% Stock Analytics
CIPLA ₹127,124.0 Cr 2.1% 3.5% -4.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,700.0 Cr -1.2% -1.7% 4.5% Stock Analytics
DR REDDYS LABORATORIES ₹109,868.0 Cr 5.3% 7.9% -2% Stock Analytics


NGL FINECHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

-3.1%

7.7%

-34.8%

SENSEX

1.5%

1.6%

0.4%


You may also like the below Video Courses